验证数据展示
经过测试的应用
Positive WB detected in | Daudi cells, Jurkat cells |
Positive IF/ICC detected in | Ramos cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:125-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
84211-4-RR targets NTB-A/SLAMF6 in WB, IF/ICC, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, IF/ICC, ELISA Application Description |
经测试反应性 | human |
免疫原 | Fusion Protein 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | SLAM family member 6 |
别名 | SLAMF6, Ly108, KALIb, KALI, CD352 |
计算分子量 | 37kDa |
观测分子量 | 60 kDa |
GenBank蛋白编号 | NM_001184714.2 |
基因名称 | SLAMF6 |
Gene ID (NCBI) | 114836 |
RRID | AB_3671768 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein A purfication |
UNIPROT ID | Q96DU3-1 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Signaling lymphocyte activation molecule 6 (SLAMF6) (Ly108 in mice, NTB-A or SF2000 in humans) is a homophilic receptor belonging to the superfamily immunoglobulin (Ig) domain-containing molecules (PMID:31199820). SLAMF6 is a type I transmembrane protein with two extracellular immunoglobins (Ig)-like domains and three cytoplasmic tyrosine-based signaling motifs, one of which is immunoreceptor tyrosine-based switch motif (PMID:31315913). SLAMF6 is expressed on a wide variety of immune cells including T cells (also TFH), B cells, NK cells (expressed in humans only), double positive thymocytes, eosinophils, and neutrophils (mouse only) (PMID:11862385).
实验方案
Product Specific Protocols | |
---|---|
WB protocol for NTB-A/SLAMF6 antibody 84211-4-RR | Download protocol |
IF protocol for NTB-A/SLAMF6 antibody 84211-4-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |